Charles Rhyee
Stock Analyst at TD Cowen
(1.04)
# 3,711
Out of 4,940 analysts
53
Total ratings
40%
Success rate
-10.46%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Downgrades: Sell | $283 → $366 | $450.48 | -18.75% | 5 | Jul 23, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $158.94 | -1.22% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $158.15 | -8.95% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $148.57 | +52.79% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $6.35 | +293.70% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $6.85 | +16.87% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $278.71 | -31.11% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $3.45 | +363.77% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.47 | +102.43% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $7.05 | +609.22% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $179.96 | +39.48% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $9.03 | +520.16% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.51 | +2,620.56% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $9.18 | +444.96% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $678.90 | -46.83% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $0.36 | +912,316.47% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $23.33 | +50.02% | 1 | Feb 13, 2018 |
Medpace Holdings
Jul 23, 2025
Downgrades: Sell
Price Target: $283 → $366
Current: $450.48
Upside: -18.75%
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $158.94
Upside: -1.22%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $158.15
Upside: -8.95%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $148.57
Upside: +52.79%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $6.35
Upside: +293.70%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $6.85
Upside: +16.87%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $278.71
Upside: -31.11%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $3.45
Upside: +363.77%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.47
Upside: +102.43%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $7.05
Upside: +609.22%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $179.96
Upside: +39.48%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $9.03
Upside: +520.16%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.51
Upside: +2,620.56%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $9.18
Upside: +444.96%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $678.90
Upside: -46.83%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $0.36
Upside: +912,316.47%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $23.33
Upside: +50.02%